Contemporary Safety of Ultrasound Enhancing Agents in a Nationwide Analysis
In this large nationwide claims analysis from 2018 to 2022, serious adverse events associated with UEAs for TTE/SE were uncommon and overall consistent across agents and years of study. Compared with nonreceipt, receipt of UEAs was associated with a lower odds of death within 2 days of TTE/SE.
Authors
- Jordan B. Strom (ORCID: https://orcid.org/0000-0002-6592-6141)
- Sharon L. Mulvagh (ORCID: https://orcid.org/0000-0002-7377-4053)
- Jessica L. Stout
- Thomas R. Porter (ORCID: https://orcid.org/0000-0003-0881-946X)
- Kevin Wei (ORCID: https://orcid.org/0009-0004-8522-4333)
- Michael L. Main
Institutions
- Dalhousie University (CA)
- Harvard University (US)
- Oregon Health & Science University (US)
- Hadassah Medical Center (IL)
- Heart Institute (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1161/jaha.124.039480
- Citations
- 5
- Primary Topic
- Ultrasound and Hyperthermia Applications
- Type
- article
- Field-Weighted Citation Impact
- 3.37